US › Healthcare

Impact BioMedical, Inc. (IBO)

US · Healthcare · Biotechnology

$4.10-6.82%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$3,000

Revenue YoY

-57.1%

Net profit

$-699,000

EPS

$-0.01

Net margin

-23,300.0%

Key statistics

Market cap

$35.4M

P/E

0.4

Forward P/E

0.0

P/B

3.53

Book value

$1.26

EPS (TTM)

$11.11

52-week high

$10.47

52-week low

$2.43

50-day MA

$5.04

200-day MA

$6.24

Beta

2.89

Shareholding

Insiders

89.50%

Institutions

3.56%

Corporate actions

Action	Detail	Date
Split	1 : 12 effective Sep 23, 2026	2026-09-23

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Impact BioMedical, Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.